高分子注射薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2413)
◆英語タイトル:Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2413
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、高分子注射薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(静脈注射、筋肉注射、皮下注射)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・高分子注射薬の市場動向
・企業の競争状況、市場シェア
・高分子注射薬の種類別市場規模(静脈注射、筋肉注射、皮下注射)
・高分子注射薬の用途別市場規模(病院薬局、小売薬局、オンライン薬局)
・高分子注射薬の北米市場規模2016-2027(アメリカ、カナダ)
・高分子注射薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・高分子注射薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・高分子注射薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・高分子注射薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Biogen、AstraZeneca、Roche、Sun Pharmaceutical、Medtronic、Novartis、​​Baxter、Amgen、Pfizer、Johnson & Johnson)
・結論
【レポートの概要】

Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.

Market Analysis and Insights: Global Large Molecule Injectable Drugs Market
The global Large Molecule Injectable Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Large Molecule Injectable Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Large Molecule Injectable Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Large Molecule Injectable Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Large Molecule Injectable Drugs market.

Global Large Molecule Injectable Drugs Scope and Market Size
Large Molecule Injectable Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Molecule Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous Injection
Muscle Injection
Subcutaneous Injection

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
​​Baxter
Amgen
Pfizer
Johnson & Johnson

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Large Molecule Injectable Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Injection
1.2.3 Muscle Injection
1.2.4 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Large Molecule Injectable Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Large Molecule Injectable Drugs Market Perspective (2016-2027)
2.2 Large Molecule Injectable Drugs Growth Trends by Regions
2.2.1 Large Molecule Injectable Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Large Molecule Injectable Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Large Molecule Injectable Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Large Molecule Injectable Drugs Industry Dynamic
2.3.1 Large Molecule Injectable Drugs Market Trends
2.3.2 Large Molecule Injectable Drugs Market Drivers
2.3.3 Large Molecule Injectable Drugs Market Challenges
2.3.4 Large Molecule Injectable Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Large Molecule Injectable Drugs Players by Revenue
3.1.1 Global Top Large Molecule Injectable Drugs Players by Revenue (2016-2021)
3.1.2 Global Large Molecule Injectable Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Large Molecule Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Large Molecule Injectable Drugs Revenue
3.4 Global Large Molecule Injectable Drugs Market Concentration Ratio
3.4.1 Global Large Molecule Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Large Molecule Injectable Drugs Revenue in 2020
3.5 Large Molecule Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Large Molecule Injectable Drugs Product Solution and Service
3.7 Date of Enter into Large Molecule Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Large Molecule Injectable Drugs Breakdown Data by Type
4.1 Global Large Molecule Injectable Drugs Historic Market Size by Type (2016-2021)
4.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2022-2027)

5 Large Molecule Injectable Drugs Breakdown Data by Application
5.1 Global Large Molecule Injectable Drugs Historic Market Size by Application (2016-2021)
5.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Large Molecule Injectable Drugs Market Size (2016-2027)
6.2 North America Large Molecule Injectable Drugs Market Size by Type
6.2.1 North America Large Molecule Injectable Drugs Market Size by Type (2016-2021)
6.2.2 North America Large Molecule Injectable Drugs Market Size by Type (2022-2027)
6.2.3 North America Large Molecule Injectable Drugs Market Size by Type (2016-2027)
6.3 North America Large Molecule Injectable Drugs Market Size by Application
6.3.1 North America Large Molecule Injectable Drugs Market Size by Application (2016-2021)
6.3.2 North America Large Molecule Injectable Drugs Market Size by Application (2022-2027)
6.3.3 North America Large Molecule Injectable Drugs Market Size by Application (2016-2027)
6.4 North America Large Molecule Injectable Drugs Market Size by Country
6.4.1 North America Large Molecule Injectable Drugs Market Size by Country (2016-2021)
6.4.2 North America Large Molecule Injectable Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Large Molecule Injectable Drugs Market Size (2016-2027)
7.2 Europe Large Molecule Injectable Drugs Market Size by Type
7.2.1 Europe Large Molecule Injectable Drugs Market Size by Type (2016-2021)
7.2.2 Europe Large Molecule Injectable Drugs Market Size by Type (2022-2027)
7.2.3 Europe Large Molecule Injectable Drugs Market Size by Type (2016-2027)
7.3 Europe Large Molecule Injectable Drugs Market Size by Application
7.3.1 Europe Large Molecule Injectable Drugs Market Size by Application (2016-2021)
7.3.2 Europe Large Molecule Injectable Drugs Market Size by Application (2022-2027)
7.3.3 Europe Large Molecule Injectable Drugs Market Size by Application (2016-2027)
7.4 Europe Large Molecule Injectable Drugs Market Size by Country
7.4.1 Europe Large Molecule Injectable Drugs Market Size by Country (2016-2021)
7.4.2 Europe Large Molecule Injectable Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Large Molecule Injectable Drugs Market Size (2016-2027)
8.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type
8.2.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application
8.3.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region
8.4.1 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Large Molecule Injectable Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Large Molecule Injectable Drugs Market Size (2016-2027)
9.2 Latin America Large Molecule Injectable Drugs Market Size by Type
9.2.1 Latin America Large Molecule Injectable Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Large Molecule Injectable Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Large Molecule Injectable Drugs Market Size by Type (2016-2027)
9.3 Latin America Large Molecule Injectable Drugs Market Size by Application
9.3.1 Latin America Large Molecule Injectable Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Large Molecule Injectable Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Large Molecule Injectable Drugs Market Size by Application (2016-2027)
9.4 Latin America Large Molecule Injectable Drugs Market Size by Country
9.4.1 Latin America Large Molecule Injectable Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Large Molecule Injectable Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Large Molecule Injectable Drugs Market Size (2016-2027)
10.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type
10.2.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application
10.3.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Large Molecule Injectable Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country
10.4.1 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Large Molecule Injectable Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Large Molecule Injectable Drugs Introduction
11.1.4 Biogen Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Large Molecule Injectable Drugs Introduction
11.2.4 AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Large Molecule Injectable Drugs Introduction
11.3.4 Roche Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Large Molecule Injectable Drugs Introduction
11.5.4 Medtronic Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Large Molecule Injectable Drugs Introduction
11.6.4 Novartis Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 ​​Baxter
11.7.1 ​​Baxter Company Details
11.7.2 ​​Baxter Business Overview
11.7.3 ​​Baxter Large Molecule Injectable Drugs Introduction
11.7.4 ​​Baxter Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.7.5 ​​Baxter Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Large Molecule Injectable Drugs Introduction
11.8.4 Amgen Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Large Molecule Injectable Drugs Introduction
11.9.4 Pfizer Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Large Molecule Injectable Drugs Introduction
11.10.4 Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 高分子注射薬の世界市場規模・現状・予測2021年-2027年(Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。